AdaptHealth (AHCO) Shares Outstanding (Weighted Average) (2017 - 2026)
AdaptHealth (AHCO) recorded quarterly Shares Outstanding (Weighted Average) of $135.8 million in Q1 2026, little changed quarter-over-quarter from $135.1 million in Q4 2025, and up 0.73% on a YoY basis from $134.8 million in Q1 2025.
AdaptHealth (AHCO) Shares Outstanding (Weighted Average) (2017 - 2026) Analysis & Trends
AdaptHealth's Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $135.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 0.73% year-over-year to $135.8 million; the TTM figure through Mar 2026 stood at $135.8 million (up 0.73% YoY), while the FY2025 annual figure was $135.1 million, up 1.04% from the prior year.
- Shares Outstanding (Weighted Average) was $135.8 million for Q1 2026 at AdaptHealth, roughly flat from $135.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $135.8 million in Q1 2026 to a low of $132.9 million in Q1 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $134.4 million across 5 years, with a median of $134.3 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) gained 20.62% in 2022, then dropped 1.2% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $134.2 million in 2022, then dropped by 0.01% to $134.2 million in 2023, then fell by 0.3% to $133.8 million in 2024, then gained by 1.04% to $135.1 million in 2025, then rose by 0.47% to $135.8 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $135.8 million (Q1 2026), $135.1 million (Q4 2025), and $135.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 579.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 456.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 385.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 98.20 Mn |
| 10 | AdaptHealth | 1.38 Bn | 1.34 Bn | 111.50 Mn | 135.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135.78 Mn |
| Dec 31, 2025 | 135.15 Mn |
| Sep 30, 2025 | 135.05 Mn |
| Jun 30, 2025 | 134.99 Mn |
| Mar 31, 2025 | 134.80 Mn |
| Dec 31, 2024 | 133.76 Mn |
| Sep 30, 2024 | 134.30 Mn |
| Jun 30, 2024 | 133.22 Mn |
| Mar 31, 2024 | 132.91 Mn |
| Dec 31, 2023 | 134.16 Mn |
| Sep 30, 2023 | 134.83 Mn |
| Jun 30, 2023 | 134.41 Mn |
| Mar 31, 2023 | 134.53 Mn |
| Dec 31, 2022 | 134.18 Mn |
| Sep 30, 2022 | 134.23 Mn |
| Jun 30, 2022 | 134.33 Mn |
| Mar 31, 2022 | 134.02 Mn |
| Dec 31, 2021 | 126.31 Mn |
| Sep 30, 2021 | 131.68 Mn |
| Jun 30, 2021 | 120.44 Mn |